| Matthew Alexander, | |
|
487 Town Center Pl, Apt 310, Columbia, SC 29229-7973 | |
| (419) 889-7303 | |
| Not Available |
| Full Name | Matthew Alexander |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 487 Town Center Pl, Columbia, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235547381 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 35711 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Alexander, 487 Town Center Place, Apt 310, Columbia, SC 29229-5703 Ph: (419) 889-7303 | Matthew Alexander, 487 Town Center Pl, Apt 310, Columbia, SC 29229-7973 Ph: (419) 889-7303 |
News Archive
Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for OFIRMEV™ (acetaminophen) injection, the first and only intravenous (IV) formulation of acetaminophen to be approved in the United States. OFIRMEV is indicated for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, and the reduction of fever.
A team from the University of Chicago Medicine Comprehensive Cancer Center has received a five-year, $3.9-million award from the National Cancer Institute to serve as a Lead Academic Participating Site for the newly created National Clinical Trials Network (NCTN).
Vermont, Kansas, Missouri, Minnesota, Texas and California are grappling with various aspects of implementing the health law.
The brains of Alzheimer patients have high accumulations of the material beta-amyloid, which appear in the form of plaques. The precursors of these plaques are believed to be the underlying cause of the nerve cell loss that leads to the disruptions in memory that characterize Alzheimer's disease. The main aim of many Alzheimer therapies is therefore to inhibit the formation of beta-amyloid. Since beta-amyloid is cleaved from the so-called amyloid precursor protein (APP), scientists have focused on stopping the two enzymes that attack the precursor protein. These act like molecular scissors and cut out the beta-amyloid fragment. Blocking these scissors precludes the formation of beta-amyloid.
The National Institute on Drug Abuse has awarded a five-year, $6.6 million grant to the University of Texas Medical Branch at Galveston to establish the Translational Addiction Sciences Center. The center will investigate the mechanisms underlying addiction with the goal of discovering and validating novel treatment options.
› Verified 4 days ago
Dr. Dargan Elizabeth Mayer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 818 Harden St, Columbia, SC 29205 Phone: 803-799-0043 | |
Dr. Brittney Brooks Mcniece, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 163 Sandhurst Rd, Columbia, SC 29210 Phone: 706-767-1170 | |
Mrs. Janna Hollis, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1326 Bush River Rd, Columbia, SC 29210 Phone: 803-750-3284 Fax: 803-750-3280 | |
Alexander Corboy, DR. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6439 Garners Ferry Rd, Columbia, SC 29209 Phone: 803-776-4000 | |
Alfred Jones, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 507 Piney Grove Rd, Columbia, SC 29210 Phone: 803-875-7140 | |
Dr. Hayley Tatro, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6439 Garners Ferry Rd, Columbia, SC 29209 Phone: 803-776-4000 | |
Dr. William Chad Hancock, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6169 Saint Andrews Rd, Columbia, SC 29212 Phone: 803-798-5957 Fax: 803-798-8837 |